Jul 28, 2004This article was originally published by RFID Update.
July 28, 2004—The U.S. Food and Drug Administration ruled Tuesday that a hospital identification system from Florida-based VeriChip will be subject to one final review for approval. Under the futuristic system, RFID chips with identification numbers would be subdermally implanted in hospital patients, allowing them to be identified and authenticated at various security points around the hospital. Given the system's novelty, the FDA said that it needed more time to consider privacy implications before granting approval. The controversial VeriChip, known for its RFID-based "human chipping" products, made headlines recently when the Mexican attorney general announced that he and more than 100 members of his staff had been chipped with the company's product.
Read the article at ZDNet UK
